About: Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 2000 (uk) article scientifique publié en 2000 (fr) im November 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en payares de 2000 (ast) scientific article published on 01 November 2000 (en)
publication date	wds:Q73234369-6067EDE4-72D0-4FA0-AB2B-196487851FD8
publication date	2000-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73234369-FFF43805-04F9-4171-927A-47EEEF9A600B
language of work or name	English
cites work	wds:Q73234369-78EFF0F3-0254-4F57-B3F4-C293E68E669C
cites work	Insulin Sensitivity and Insulin Binding to Monocytes in Maturity-Onset Diabetes
author name string	wds:Q73234369-3C3ACF9A-D7CC-4FD3-B449-D784E2EC2080 wds:Q73234369-59114A23-51A1-4B8D-8956-9B3A892FEEFD wds:Q73234369-7029B48E-7895-4582-9BF4-C465C5552ADC wds:Q73234369-79ED370A-1A44-4C17-B1DF-1194778B53DB wds:Q73234369-C0485839-9E66-4349-AC3A-40D8743DD528 wds:Q73234369-EFCC6521-39FD-453E-A184-8ED1A5AF3739
author name string	A Vella P Shah R A Rizza A Basu R Basu W F Schwenk
rdfs:label	Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus (en) Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus (nl)
skos:prefLabel	Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus (en) Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus (nl)
name	Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus (en) Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus (nl)
title	wds:Q73234369-8CEC4504-A58D-4E64-A1B6-E0EC9199BDFA
title	Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus (en)
page(s)	wds:Q73234369-CB118208-92CF-4634-B5EF-7DB2C5779364
page(s)	4053-4059
instance of	wds:Q73234369-63729ACE-72E9-49D4-BF89-5BE9CD198D98
instance of	scholarly article
main subject	wds:Q73234369-0FD7C3B6-3BDA-42DD-BE3A-76541CE7BAEA wds:Q73234369-1655BDC9-2C1D-4E16-B184-2A5FA63505AE wds:Q73234369-E8CB1C44-76AF-407C-BB18-199C15ACC243
main subject	glucagon type 2 diabetes hyperglycemia
PubMed ID	wds:Q73234369-3D7AF648-B6FF-4A19-B769-F79FB0FC55F3
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11095432
PubMed ID	11095432
published in	wds:Q73234369-D010B0CF-4D13-4FFF-B8FE-90199BD92C14
published in	The Journal of Clinical Endocrinology and Metabolism
issue	wds:Q73234369-3CBCAA26-1744-4685-B3FD-9E2CF9CB7F87
volume	wds:Q73234369-FDCBBAA3-1553-470B-BE0C-62DD700F0CD8
issue	11
volume	85
DOI	wds:Q73234369-9DBBB4C9-131B-4C99-9DD4-F1D4BF951882
DOI	http://dx.doi.org/10.1210/JCEM.85.11.6993
DOI	10.1210/JCEM.85.11.6993
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73234369
is cites work of	Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas β- and α-cell dysfunctions in africans with ketosis-prone atypical diabetes during near-normoglycemic remission Glucagon as a critical factor in the pathology of diabetes The alpha-cell as target for type 2 diabetes therapy. FGF-21 as a novel metabolic regulator The diterpene glycoside, rebaudioside A, does not improve glycemic control or affect blood pressure after eight weeks treatment in the Goto-Kakizaki rat. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Production of functional glucagon-secreting α-cells from human embryonic stem cells Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors Anti-diabetic efficacy and impact on amino acid metabolism of GRA1, a novel small-molecule glucagon receptor antagonist New drugs for type 2 diabetes mellitus: what is their place in therapy? What is type 2 diabetes? Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes Ectopic expression of GIP in pancreatic β-cells maintains enhanced insulin secretion in mice with complete absence of proglucagon-derived peptides. K(ATP) channels and islet hormone secretion: new insights and controversies Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus Regulated exocytosis of GABA-containing synaptic-like microvesicles in pancreatic beta-cells. Using Drosophila to discover mechanisms underlying type 2 diabetes Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20-34. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia Taking aim at islet hormones with GLP-1: is insulin or glucagon the better target? cAMP activates TRPC6 channels via the phosphatidylinositol 3-kinase (PI3K)-protein kinase B (PKB)-mitogen-activated protein kinase kinase (MEK)-ERK1/2 signaling pathway. Glucagon and type 2 diabetes: the return of the alpha cell. Islet α cells and glucagon--critical regulators of energy homeostasis Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling? Alterations of glucose metabolism in type 2 diabetes mellitus. An overview MitoNEET-Parkin Effects in Pancreatic α- and β-Cells, Cellular Survival, and Intrainsular Cross Talk Pancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the Block Blood Glucagon Levels Predict the Hemoglobin A1c Response to Saxagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Beta- and alpha-cell dysfunction in subjects developing impaired glucose tolerance: outcome of a 12-year prospective study in postmenopausal Caucasian women Can stevioside in combination with a soy-based dietary supplement be a new useful treatment of type 2 diabetes? An in vivo study in the diabetic goto-kakizaki rat. Enhancement of glucagon secretion in mouse and human pancreatic alpha cells by protein kinase C (PKC) involves intracellular trafficking of PKCalpha and PKCdelta Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action Physiologic action of glucagon on liver glucose metabolism Differential contribution of dietary fat and monosaccharide to metabolic syndrome in the common marmoset (Callithrix jacchus) Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes Glucagon receptor-mediated extracellular signal-regulated kinase 1/2 phosphorylation in rat mesangial cells: role of protein kinase A and phospholipase C. Intra-islet glucagon secretion and action in the regulation of glucose homeostasis Improving Effect of the Acute Administration of Dietary Fiber-Enriched Cereals on Blood Glucose Levels and Gut Hormone Secretion Bone marrow transplantation reverses new-onset immunoinflammatory diabetes in a mouse model. Dual mode of glucagon receptor internalization: role of PKCα, GRKs and β-arrestins

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software